Abstract:
Human Papillomavirus (HPV) vaccines are vaccines used for vaccination against human papillomavirus infection.
HPV vaccines prevent infection from different types of human papillomavirus which cause risk for cervical cancer. Vaccination with different types of HPV has an impact on the health of the population.
Goal: The information for benefit-risk of the HPV types vaccines used for the protection of the population against infection.
Biography:
Merita Kucuku studied Master degree: “Chemical Analysis and Determination of the structure by Instrumental Analysis” and Master theses:” Validation and optimization of the determination method of merthiolate in the vaccine by spectrophotometer by means of Factorial Design “Studied Ph. D: “Study and chemical- analytical evaluation of some vaccines used in Albania”. More than 10 years of experience in the field of safety and efficacy and regulatory issues of vaccines, Head of National Regulatory Authority of Vaccines & Immunobiological Products in Albania, and experience as Head of Control Laboratory of medicines in the National Agency for Medicines & Medical Devices (NAMMD). Trained in international agencies and organizations for: Safety, efficacy, AEFI and quality control of vaccines, and GMP. Quality Control/ Quality assurance of laboratories (ISO 17025). Environmental issues as: Environmental Impact Assessment (EIA) and Strategic Environmental, Assessment (SEA), “Strategies for chemicals management”, (Pharmaceutical waste management). Training for instrumental analysis as GC, GC- MS. Basic toxicology. National expert on the identification of populations at risk and gender dimensions under MIA project, UNDP. Expert in the project:” Strengthening of capacities for chemical management in Albania”, arranged from UNITAR.
